About 18S rRNA (guanine-N(7))-methyltransferase
18S rRNA (guanine-N(7))-methyltransferase (BUD23) is a protein
from Homo sapiens identified by UniProt accession
O43709, 281 residues long.
MolForge cross-references it against 0 known binders and
41 disease associations.
Target properties
| Protein name | 18S rRNA (guanine-N(7))-methyltransferase |
| UniProt accession | O43709 |
| Gene | BUD23 |
| Organism | Homo sapiens |
| Length | 281 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (41)
Diseases linked to this target (Open Targets).
- IGF-1 measurement · score 0.18
- appendicular lean mass · score 0.09
- MODY · score 0.07
- 3-hydroxy-3-methylglutaryl-CoA synthase deficiency · score 0.05
- hyperproinsulinemia · score 0.05
- exercise-induced hyperinsulinism · score 0.04
- Glycogen storage disease due to hepatic glycogen synthase deficiency · score 0.04
- glycogen storage disorder due to hepatic glycogen synthase deficiency · score 0.04
- lean body mass · score 0.04
- alcohol consumption measurement · score 0.04
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O43709-F1 | alphafold | PREDICTED | 87.73 | — |
Amino-acid sequence (281 residues)
MASRGRRPEH GGPPELFYDE TEARKYVRNS RMIDIQTRMA GRALELLYLP ENKPCYLLDI GCGTGLSGSY LSDEGHYWVG LDISPAMLDE AVDREIEGDL LLGDMGQGIP FKPGTFDGCI SISAVQWLCN ANKKSENPAK RLYCFFASLF SVLVRGSRAV LQLYPENSEQ LELITTQATK AGFSGGMVVD YPNSAKAKKF YLCLFSGPST FIPEGLSENQ DEVEPRESVF TNERFPLRMS RRGMVRKSRA WVLEKKERHR RQGREVRPDT QYTGRKRKPR F
Explore 18S rRNA (guanine-N(7))-methyltransferase with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets